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Given their relationship with metabolic syndrome and systematic inflammatory diseases, the 
pathogenesis of hypertension, hyperglycemia, and hyperlipidemia is closely related. To explore the 
common genes among these three conditions, spontaneous hypertensive rats (SHR), spontaneous 
diabetic Goto-Kakizaki rats (GK) and hyperlipidemia rats (HMR) were reared for experiments. Gene 
array was used to identify the genes of SHR, GK and HMR compared with normal Wistar rats using 
TBtools software. First, real-time PCR was applied to verify these genes, and Cytoscape software 
was used to construct networks based on the National Center for Biotechnology Information (NCBI) 
database. Second, Kyoto Encyclopedia of Genes and Genomes (KEGG) database analysis was 
performed to classify the genes. Visualization and Integrated Discovery (DAVID) database and Gene 
Ontology database were used to explore the biological function. Finally, Onto-tools Pathway Express 
was used to analyze the pathways of shared genes. Importantly, upregulated common genes, such as 
Bad, Orm1, Arntl and Zbtb7a, were used to construct a network of 150 genes, while downregulated 
genes, such as Mif and Gpx1, formed a network of 29 genes. Interestingly, the networks were 
involved in various pathways, such as insulin signal pathway, endometrial cancer pathway, circadian 
rhythm pathway, and pancreatic cancer pathway. We discovered common genes of SHR, GK and 
HMR compared with normal Wistar rats, and the association of these genes together with biological 
function were preliminarily revealed.
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INTRODUCTION
Hypertension, diabetes and hyperlipidemia 
are common and frequently encountered chronic 
noncommunicable diseases that pose a serious risk to 
human health. Recently, the number of people with 
hypertension, diabetes and hyperlipidemia has been 
sharply increasing (Je et al., 2017), and the majority 
of these patients has a combination of dysarteriotony, 
pathoglycemia and dyslipidemia (Chen et al., 2016; 
Patel et al., 2016). 
Moreover, dyslipidemia, hyperglycemia, 
hypertension, hypercholesterolemia and abdominal 
obesity are characterized by a cluster of interdependent 
disorders (Mohammadbeigi et al., 2018), triggering a 
collection of metabolic abnormalities (Takeyama et al., 
2018), such as heart disease, thrombosis, vasomotor 
dysfunction in microvessels, mitochondrial function 
disorder, diabetic nephropathy and renal interstitial 
fibrosis (Rahmatallah et al., 2017) (Hye Khan et 
al., 2018). In a recent study, Lee et al. identified an 
overexpression of metabolic disease related-gene related 
to the upregulation of the inflammatory-related factors 
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interleukin (IL)-6 and tumor necrosis factor (TNF)-
alpha (Lee et al., 2018). Furthermore, Adamts18-
knockout mice with increased expression of enhancer 
binding protein beta exhibited hypertension, blood 
glucose metabolic disorder and hyperlipidemia (Zhu 
et al., 2018).
Additionally, previous retrospective trials 
suggested that hypertension was associated with 
the development of cancer (Dyer et al., 1975; Buck, 
Donner, 1987; Wannamethee, Shaper, 1996; Felmeden, 
Lip, 2001; Jeong et al., 2015). Existing drugs that are 
used to treat hypertension, such as Angiotensin II 
receptor antagonists (ARB), exhibit potential in the 
treatment of endometrial cancer (Choi et al., 2012). 
In addition, during the treatment process, one study 
used Kaplan-Meier analysis to reveal that the most 
common statin monotherapy exhibited a potentially 
protective effect against colorectal cancer-related 
mortality (Yokomichi et al., 2017). As an anabolic 
hormone, insulin promotes cell proliferation and the 
progression of cancer through a variety of channels 
(Parekh et al., 2009). Based on the abovementioned 
studies, a potential relationship was noted among 
hypertension, diabetes and hyperlipidemia that was 
also associated with other systematic inflammatory 
diseases regardless of the disease development stage 
or treatment period.
However, previous studies have explored the 
key genes or the significant pathways that impact 
the diseases. At present, microarray technology and 
high-throughput sequencing have been widely used 
to screen for differential gene expression in diseases 
(C. Wu et al., 2018). Thus, we proposed that an 
intrinsic genetic relationship potentially exists among 
hypertension, diabetes and hyperlipidemia. The aim of 
the present study is to explore the shared genes of SHR, 
GK and HMR compared with normal Wistar rats based 
on microarray technology and analyze the biological 




Spontaneous hypertensive rats (SHR) (n=6), 
spontaneous diabetic Goto-Kakizaki rats (GK) (n=6) 
and hyperlipidemia rats (HMR) (n=6) were selected 
to serve as experimental groups. These rats were 
compared with normal Wistar rats. All of the rats 
were obtained from the Chinese National Rodent 
Laboratory Animal Resources Shanghai Branch. 
HMR were duplicated by feeding Wistar rats with a 
high fat diet that contained 60% general feed, 12% 
lard, 5% sucrose, 5% milk powder, 5% peanut, 5% 
hen eggs, 1% sesame oil and 2% salt for 90 days. The 
serum triglyceride levels were increased compared 
with that of the general feed groups (p<0.05). This 
work was performed in accordance with the EU 
Directive 2010/63/EU for animal experiments.
RNA preparation
Livers were isolated from SHR, GK, HMR and 
normal Wistar rats that were anesthetized with inactin 
(80 mg/kg, intraperitoneally). Total RNA was isolated 
from liver tissues using TRI Reagent (Molecular 
Research Center, Inc., Cincinnati, OH) according to 
the manufacturer’s protocol. Potential impurities were 
removed (RNeasy Mini Kit, Qiagen, Valencia, CA). 
Gene expression analysis
Probe preparation and hybridization were 
performed according to protocols recommended by 
Shanghai BioChip. A software package was used 
to collect fluorescent intensity signals from Agilent 
scanner with 10-μm resolution, and expression data were 
normalized with Genespring and summarized using a 
multiarray analysis. Comparison analyses were used to 
discriminate changes in gene expression levels between 
the experimental group and normal group. cDNA direct 
labeling was adopted in this experiment. Cy3 fluorescent 
labeling was applied in experimental group, and Cy5 
fluorescent labeling was used in control group. The 
ratio value could be calculated (Cy3/Cy5) in the same 
microarray. The screening standard of differentially 
expressed genes was employed. Specifically, a ratio≥2 
indicates upregulation, while a ratio≤0.5 indicates 
downregulation.
Then, downregulated genes and upregulated 
genes from the SHR, GK and HMR microarrays were 
identified by comparison with normal Wistar rats, and 
shared downregulated and upregulated genes were 
analyzed using TBtools v 0.5 software. 
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Confirmation of changes in gene 
expression by SYBR Green RT-PCR
SYBR Green real-time polymerase chain reaction 
(RT-PCR) was performed for several genes to confirm 
the hybridization results. Using samples from the array 
experiments, 5 μg of total RNA was reverse transcribed 
into cDNA using the Superscript First Strand System 
for RT-PCR (Invitrogen). Then, each cDNA sample 
was used as a template for real-time PCR amplification 
by applying SYBR green PCR Master Mix (Applied 
Biosystems) and forward/reverse primers for the various 
target genes (Table I). Amplification and detection were 
performed on an ABI Prism 7000 Real-Time PCR 
system according to the manufacturer’s instructions 
using a two-stage cycle of 95 °C for 15 s and 59 °C for 
1 min that was repeated for 40 cycles and followed by a 
dissociation stage. Relative fold mRNA expression levels 
were determined via the 2–ΔΔCt method using GAPDH as 
housekeeping control.
Network analysis 
Cytoscape v 3.5.1 software was used to construct 
networks by importing networks from NCBI Entrez 
Eutilities Web Service Client.
Analysis of differentially expressed genes
The Kyoto Encyclopedia of Genes and Genomes 
(KEGG) (http://www.kegg.jp/) is a collection of 
online databases dealing with genomes, enzymatic 
pathways, and biological chemicals. KEGG considers 
genes and expression information as a whole to study 
systematically the function of genes. We applied KEGG 
analysis to classify the differentially expressed genes. 
The Database for Annotation, Visualization and 
Integrated Discovery (DAVID) provides a comprehensive 
set of functional annotation tools for investigators to 
understand the biological meaning of large lists of 
genes (https://david.ncifcrf.gov/) to identify enriched 
biological themes, particularly GO terms, and to explore 
gene names in batch and display related many-genes-to-
many-terms by 2-D view. We applied DAVID to analyze 
The Biological Process and The Cell Component.
The Gene Ontology platform (http://geneontology.
org/) analyzes many functions of genes, such as cellular 
component organization, molecular activities of gene 
products, pathways and larger processes composed of the 
activities of multiple gene products. We applied DAVID to 
analyze The Protein Class and The Molecular Function.
GO enrichment and DAVID database analyses 
were performed using the 8 genes with significantly 
increased expression and the 13 genes with significantly 
decreased expression. Significant GO term enrichment 
and DAVID data were defined according to the P-value 
using a cut-off value of 0.05.
Pathway analysis 
Analysis of the most biologically relevant disease 
pathways shared genes was performed by using the web-
TABLE I - Forward and reverse primer
GenBank ID Forward primer 5'-3' Reverse primer 5'-3' Length
AI012209 CACCTCATTGAAGCCATCCA GAAGGAAGGCGGAGAGAACAT 133
NM_022698 AGTTGGACGCGCATTATCCA TTCCGCCCACACCCAATAT 135
AY011147 CAATTCTCCTAGCACAAGTGTTGAC AAAGCACGCCTGTGTTGG 122
NM_144739 TGACTGTGCGTGTCCTCATGCT TAGATGGCGCTTTCCAGTGGA 107
NM_053607 AGCAAAGCAACGTGGACGA TGGCAGCAAAATACTGCAGG 112
NM_031051 CCAGAACCGCAACTACAGCAA TGGCTGCGTTCATGTCGTAA 104
GAPDH TCCTGCACCACCAACTGCTTAG AGTGGCAGTGATGGCATGGACT 102
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based tools Onto-tools Pathway Express (http://vortex.
cs.wayne.edu). An impact factor (IF) was calculated for 
each pathway by incorporating parameters, such as the 
normalized fold change of the differentially expressed 
genes, the statistical significance of the set of pathway 




To unveil the potential relations among 
hypertension, diabetes and hyperlipidemia based on 
pathogenesis, SHR, GK and HMR were selected to serve 
as experimental groups, and normal Wistar rats served 
as control. Total RNAs were isolated from their liver 
tissues, and gene expression analysis was performed 
using cDNA microarray. Compared with normal Wistar 
rats, significant up or down regulated common genes 
were identified from SHR, GK and HMR groups using 
TBtools software (Figure 1, Table II and Table III) and 
were confirmed by real-time PCR (Table IV). These 
results revealed that the pathogenesis of hypertension, 
diabetes and hyperlipidemia shared common genes. 
The results hinted that hypertension, diabetes and 
hyperlipidemia interact during onset, which suggests 
that the genetic origins of hypertension, diabetes and 
hyperlipidemia might be shared.
FIGURE 1 - Upregulated and downregulated common genes 
were identified from SHR, GK and HMR microarrays using 
TBtools software. (A) Set_1 represents 149 upregulated genes 
from the HMR group compared with the normal group; Set_2 
represents 569 upregulated genes from the GK group compared 
with the normal group; Set_3 represents 322 upregulated 
genes from the SHR group compared with the normal group; 
The intersection of the three regions in the center represents 
8 common upregulated genes in SHR, GK and HMR groups 
compared with the normal group; (B) Set_1 represents 162 
downregulated genes in the HMR group compared with the 
normal group; Set_2 represents 53 downregulated genes in the 
GK group compared with the normal group; Set_3 represents 
67 downregulated genes in the SHR group compared with 
the normal group; The intersection of the three regions in the 
center represents 13 common downregulated genes in SHR, 
GK and HMR groups compared with the normal group.





AI012209 4.56 2.7 2.02 Similar to WW domain-containing protein 2, mRNA.
XM_131329 6.54 4.0 2.29 Mitogen-activated protein kinase 7, mRNA.
XM_135927 19.64 5.0 2.14 Mus musculus RIKEN cDNA, mRNA.
NM_053288 Orm1 34.63 2.3 2.93 Rattus norvegicus Orosomucoid 1 (Orm), mRNA.
NM_022698 Bad 2.68 5.1 3.46 Rattus norvegicus bcl-2-associated death agonist, mRNA.
NM_054002 Zbtb7a 2.19 2.3 2.01
Rattus norvegicus zinc finger and BTB 
domain containing 7a, mRNA.
(continuing)
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NM_024362 Arntl 2.33 2.9 3.56
Rattus norvegicus aryl hydrocarbon receptor nuclear.
translocator-like, mRNA
L22654 9.75 4.5 2.28
Rat anti-acetylcholine receptor antibody gene, rearranged Ig
gamma-2a chain, mRNA.
Ratio value was calculated (Cy3/Cy5). A ratio≥2 indicates upregulation, which served as the screening standard of differential 
gene expression.





M91235 0.32 0.44 0.29 Rattus norvegicus transposon VL30, complete sequence.
AI236753 0.45 0.28 0.18 EST233315 Rattus norvegicus cDNA.
AY011147 0.21 0.41 0.36
Rattus norvegicus 16S ribosomal RNA gene, 
partial sequence. mitochondrial.
NM_144739 Fmo5 0.31 0.34 0.27 Rattus norvegicus flavin containing monooxygenase 5 (Fmo5), mRNA.
NM_019286 Adh1 0.31 0.34 0.19 Rattus norvegicus alcohol dehydrogenase 1 (class I) (Adh1), mRNA.
NM_030826 Gpx1 0.38 0.50 0.47 Rattus norvegicus glutathione peroxidase 1 (Gpx1), mRNA.
BG665142 0.35 0.43 0.32 DRABZA08 Rattus norvegicus cDNA.
NM_031835 AGT2 0.31 0.32 0.39
Rattus norvegicus beta-alanine-pyruvate 
aminotransferase (AGT2), mRNA.
NM_053607 Facl5 0.39 0.47 0.38 Rattus norvegicus long-chain fatty acid coenzyme A ligase 5, mRNA.
NM_02254777 Fthfd 0.37 0.44 0.45
Rattus norvegicus 10-formyltetrahydrofolate 
dehydrogenase. (Fthfd).mRNA.
AI535168 0.18 0.44 0.32 UI-R-C3-sq-d-05-0-UI. s1 Rattus norvegicus cDNA.
BF284744 0.37 0.38 0.37 EST449335 Rattus norvegicus cDNA.
NM_031051 Mif 0.13 0.36 0.28 Rattus norvegicus macrophage migration inhibitory factor (Mif) mRNA.
Ratio value could be calculated (Cy3/Cy5). A ratio≤0.5 indicates down regulation which served as the screening. standard of 
differential gene expression.
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TABLE IV - Real-time PCR confirmation of array results 
Locus
Array Ratio PCR(2–ΔΔCt)
HMR GK SHR HMR GK SHR
AI012209 4.56 2.78 2.02 1.85 1.19 1.93
NM_022698 2.68 5.13 3.46 50.59 16.43 34.85
AY011147 0.21 0.41 0.36 0.35 0.24 0.30
NM_144739 0.31 0.34 0.27 0.38 0.18 0.33
NM_053607 0.39 0.47 0.38 0.22 0.28 0.24
NM_031051 0.13 0.36 0.28 0.22 0.39 0.35
Relative expression levels of the six genes were consistent with microarray data. 
Network analysis of the shared genes 
Cytoscape was applied to further explore the 
network of those shared genes, upregulated shared 
genes such as Bad, Orm1, Arntl and Zbtb7a, etc. were 
found constructing network with 150 genes in Figure 2, 
while common downregulated shared, such as Fmo5, 
AGT2, Mif and Gpx1, formed a network with 29 genes 
in Figure 3.
Biological function analysis of the shared genes
These shared genes were classified by KEGG to 
explore potential correlations among the genes. We found 
that the genes covered five main functions, including 
inflammation, apoptosis, metabolism, oxidative stress 
and signal transduction (Table V). This finding implied 
that the development of hypertension, diabetes and 
hyperlipidemia was anfractuous. The pathogenesis of 
these conditions may involve common pathways. 
Shared genes were analyzed using the DAVID data 
bank to explore the categories of Biological Processes 
and Cellular Component. Biological Processes involved 
in hypertension, diabetes, hyperlipidemia included 
response to glucose (25%), cell proliferation (25%), 
oxidation-reduction process (25%), cellular response 
to hypoxia (16.7%), and organ regeneration 16.7% in 
Figure 4A. 
FIGURE 2 - Network of upregulated shared genes. (A) 
Network of upregulated shared genes based on Cytoscape v 
3.5.1 software; (B) Red circular nodes in the center of network 
represent upregulated genes common to hypertension, 
diabetes and hyperlipidemia. The outer ring was constructed 
by green rectangular nodes of first neighbor genes of those 
in center.
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FIGURE 3 - Network of downregulated shared genes. (A) 
Network of downregulated shared genes based on Cytoscape 
v 3.5.1 software; (B) Red circular nodes in the center of 
the network represent downregulated genes common to 
hypertension, diabetes and hyperlipidemia. The outer ring 
was constructed by green rectangular nodes of first neighbor 
genes of those in center.
Shared genes were analyzed using the Gene 
Ontology data bank to explore the categories of Protein 
Class and Molecular Functions. Protein Class analysis 
revealed the following functions, which were generally 
consistent with Gene Ontology data: oxidoreductase 
(44.4%), transcription factor (22.2%), ligase (11.1%), 
transferase (11.1%), and nucleic acid binding (11.1%) 
in Figure 4B. Molecular Functions included catalytic 
activity 60%, transporter activity (10%), antioxidant 
activity (10%) and binding (20%) in Figure 4C. The 
Cellular Component corresponding to these genes 
included mitochondrion (50%), cytosol (33.3%), 
blood microparticle (16.70%), and mitochondrial outer 
membrane (16.70%) in Figure 4D.
Pathways of the shared genes 
In the final step, we analyzed the shared pathways 
using the Onto-tools Pathway Express to verify close 
relationships between genes. This program processed a 
list of input genes to identify KEGG pathways based on 
fold-change, pathway position and pathway topology. One 
novel discovery was that the genes shared among the SHR, 
GK and HMR groups exhibited close relationships with 
cancers pathway, such as the endometrial cancer pathway, 
circadian rhythm pathway, pancreatic cancer pathway, 
colorectal cancer pathway, and prostate cancer pathway in 
Figure 5. The higher the impact factor is, the greater the 
probability that the pathway is involved in the disease.
DISCUSSION
The cause of hypertension, diabetes and 
hyperlipidemia has not been fully clarified. Gender, 
age, drinking, environmental and genetic factors 
are involved in the pathogenesis of these diseases. 
However, genetic factors play critical roles in the 
pathogenesis of cardiovascular diseases (Zhao et al., 
2017). In this study, the shared genes of SHR, GK and 
HMR via comparison with normal Wistar rats were 
determined via microarray analysis. 
In a previous study, Hindle, AK et al. conducted 
a microarray analysis using in the monumental tissue 
of morbidly obese diabetic and nondiabetic patients 
(Hindle et al., 2010). However, the study by Hindle, AK 
et al. did not incorporate gene expression differences for 
other cardiovascular diseases. Similarly, in the study by 
You, Z et al., obesity, hyperlipidemia, diabetes mellitus, 
and hypertension were associated with UII gene deletion 
(You et al., 2012). This study also demonstrated that a 
single causal gene had an impact on metabolic diseases. 
In contrast, multiple related risk factors and susceptible 
genes were involved in hypertension, diabetes and 
hyperlipidemia (Sun et al., 2012). Thus, microarrays can 
be performed to analyze the expression levels of copious 
genes simultaneously combined with bioinformatics 
analysis to identify associated pathways and key genes 
within complex diseases (Wu et al., 2018).
The principal finding of this study was that Bad, 
Orm1, Arntl, Zbtb7a, Mif and Gpx1 were identified 
from the hypertension, diabetes and hyperlipidemia 
rats. In addition, AI236753, AI236753, AY011147, 
XM_131329, and XM_135927, which are not well known, 
were identified from multi-experiment microarray 
comparisons (Table II and Table III). In this sense, these 
identified genes may collectively regulate the biological 
process, signal pathways and molecular mechanisms of 
these three diseases.
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FIGURE 4 - Biological Process analysis based on DAVID data bank and GO enrichment analysis of differentially expressed 
genes. (A) Biological Process enrichment; (B) Protein Class analysis; (C) Molecular Function enrichment; (D) Cell Component 
enrichment.
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TABLE V- Gene classification based on functions
Inflammation Apoptosis Metabolism Oxidative stress Signal transduction
NM_144739 NM_030826 NM_031835 NM_054002 XM_131329
NM_053288 NM_031835 A1236753 NM_022698 NM_031835
NM_031051 NM_144739 NM_019286 NM_053607 XM_135927
BF284744 NM_024362 NM_022547
M91235
FIGURE 5 - Pathway analysis of shared genes in SHR, GK and HMR using Onto-tools Pathway Express. Pathways were 
associated with the circadian rhythm pathway, endometrial cancer pathway, pancreatic cancer pathway, etc. 
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Some points should be considered in the 
interpretation of the results of the present study. 
Valencia et al. and Y. Wu et al. reported that the 
GPx1 (Rattus norvegicus Glutathione peroxidase 1) 
gene could reduce the expression of the p53 gene (Y. 
Wu et al., 2014), endothelial damage, mitochondrial 
dysfunction and reactive oxygen species accumulation 
in metabolic syndrome (Valencia et al., 2016). 
More specifically, the function of GPx1 in most 
aortic regions could also reduce diabetes-associated 
atherosclerosis and protect mice from renal structural 
and functional disorders (Chew et al., 2010). These 
findings were consistent with those presented in Figure 
(4A, 4B, 4C, 4D). Specifically, the oxidation-reduction 
process separately accounted for Go:0055114 (25%), 
oxidoreductase (44.4%), antioxidant activity (10%), 
and mitochondrion (50%). 
To demonstrate adequate agreement and validate 
microarray results, a previous study reported that 
ARNTL (Aryl Hydrocarbon Receptor Nuclear 
Translocator-Like) was characterized as the crucial 
gene involved in energy homeostasis, Type 2 diabetes, 
hypertension, and circadian rhythm (Shimba et 
al., 2011). Additionally, a genetic association study 
of 1,304 individuals from 424 families primarily 
selected for type 2 diabetes revealed that ARNTL 
was associated with type 2 diabetes and hypertension 
(Woon et al., 2007). Crucially, recent studies have 
validated ARNTL as a novel anti-oncogene to control 
progression by activating the p53 tumor suppressor 
pathway in pancreatic cancer (Jiang et al., 2016; 
Kiessling et al., 2017). Interestingly, these findings 
were consistent with the biological pathways identified 
in this study, which were associated with the circadian 
rhythm pathway, endometrial cancer pathway, and 
pancreatic cancer pathway in Figure 5.
To date, previous studies exclusively investigated 
some key genes and significant pathways to identify 
the effects on the disease of hypertension, diabetes 
and hyperlipidemia. However, in the present study, the 
shared genes identified from these three diseases via 
gene microarray analysis were first conducted to assess 
the relationship with disease through bioinformatics 
analysis. Moreover, more studies are needed to 
identify the roles in the hypertension, diabetes and 
hyperlipidemia, leading to new breakthroughs in 
etiopathogenesis, prevention and treatment.
CONCLUSION
In summary, the network genes that we constructed 
by Cytoscape revealed the complex interaction of the 
shared genes from SHR, GK and HMR compared 
with normal Wistar rats, such as Bad, Orm1, Arntl, 
Zbtb7a, Mif and Gpx1, which could affect the related 
pathways by influencing inflammatory factors, 
apoptosis factors, metabolic factors, oxidative factors 
and signal transduction factors, such as the circadian 
rhythm pathway, endometrial cancer pathway, apoptotic 
pathway, and insulin signaling pathway.
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